ImmuCell Corporation
ICCCNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $97.04M
- P/E (TTM)
- 123.24
- Forward P/E
- 243.60
- Dividend yield
- -
- 52-week range
- $4.52$12.10
- Volume (live)
- -
- Avg. volume (3M)
- 12.81K
ImmuCell (ICCC) Stock Price & Financial Analysis
ImmuCell Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.57 - $10.78 |
|---|---|
| 52-Week High | $12.10 |
| 52-Week Low | $4.52 |
| Open | $10.78 |
| Volume (last close) | 2.90K |
| Average Volume (3M) | 12.81K |
| Revenue (TTM) | 30.68M |
|---|---|
| Net Income (TTM) | 787.37K |
| Free Cash Flow (TTM) | 4.21M |
| EPS (TTM) | $0.09 |
| Profit Margin | 2.57% |
| Operating Margin | 12.60% |
| Return on Equity (ROE) | 2.51% |
| Debt to Equity | 0.40 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 97.04M |
|---|---|
| Shares Outstanding | 9.19M |
| P/E Ratio (TTM) | 123.24 |
| Forward P/E | 243.60 |
| Price to Sales (P/S) | 3.16 |
| Price to Book (P/B) | 3.09 |
| EV/EBITDA | 27.95 |
| 50-Day MA | $10.06 |
|---|---|
| 200-Day MA | $8.62 |
| 1-Year Change | +74.26% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
ImmuCell at a Glance
As of the Oct 16, 2026 close, ImmuCell (ICCC) has a market capitalization of $97.04M. The stock trades at 123.2× trailing earnings, 243.6× forward earnings and 3.2× sales. Over the trailing twelve months it earned $787.37K on revenue of $30.68M (a 2.6% profit margin) and generated $4.21M of free cash flow. Revenue grew 8.5% year over year.
As of its latest reported balance sheet, it holds $8.86M in cash and securities against $12.45M of debt, a net debt position of $3.59M.
ImmuCell does not currently pay a dividend.
The share price is up 74.3% over the past year. At $10.75 (the Oct 16, 2026 close) it sits within its 52-week range of $4.52 to $12.10, above its 200-day moving average of $8.62.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About ImmuCell
What is the current stock price for ICCC?
As of the Oct 16, 2026 close, ICCC stock trades at $10.75. The 52-week range is $4.52–$12.10, with a day range of $10.57–$10.78.
What is the P/E ratio for ICCC?
As of the Oct 16, 2026 close, ImmuCell's trailing twelve-month (TTM) P/E ratio is 123.2, meaning investors pay $123.2 for every $1 of annual earnings. The forward P/E is 243.6, reflecting analyst expectations for future earnings. ImmuCell operates in the Healthcare sector.
Does ICCC pay dividends?
ImmuCell does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ICCC?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ICCC is Buy.
What is the market cap of ICCC?
As of the Oct 16, 2026 close, ImmuCell's market capitalization is $98.8M, classifying it as a micro-cap company. ImmuCell operates in the Healthcare sector within the Biotechnology industry.